Koyfin Home > Directory > Health Care > Acceleron Pharma > Price / Sales (ltm)

Acceleron Pharma Price / Sales (ltm) Chart (XLRN)

Acceleron Pharma annual/quarterly Price / Sales (ltm) from 2013 to 2020.
  • Acceleron Pharma Price / Sales (ltm) for the quarter ending September 09, 2020 was 73.91 a -1.17% decrease of -0.86 year over year
  • Acceleron Pharma Price / Sales (ltm) for the last 12 months ending September 09, 2020 was 73.91 a -1.17% decrease of -0.86 year over year
  • Acceleron Pharma Annual Price / Sales (ltm) for 2020 was 73.91 a 2.88% increase of 2.13 from 2019
  • Acceleron Pharma Annual Price / Sales (ltm) for 2020 was 71.78 a -5.75% decrease of -4.13 from 2019
  • Acceleron Pharma Annual Price / Sales (ltm) for 2020 was 75.91 a 1.50% increase of 1.14 from 2019
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin

Quarterly XLRN Price / Sales (ltm) Data

09/202073.91
09/202071.78
09/202075.91
09/202074.77
09/202073.22
09/202072.83
09/202071.23
09/202069.18
09/202069.63
09/202067.66

Annual XLRN Price / Sales (ltm) Data

202073.91
202071.78
202075.91
202074.77
202073.22
202072.83
202071.23
202069.18
202069.63
202067.66